The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity
Open accessAbstract
A novel antiinfective approach is to exploit stresses already imposed on invading organisms by the in vivo environment. Fe metabolism is a key vulnerability of infecting bacteria because organisms require Fe for growth, and it is critical in the pathogenesis of infections. Furthermore, humans have evolved potent Fe-withholding mechanisms that can block acute infection, prevent biofilm formation leading to chronic infection, and starve bacteria that succeed in infecting the host. Here we investigate a "Trojan horse" strategy that uses the transition metal gallium to disrupt bacterial Fe metabolism and exploit the Fe stress of in vivo environments. Due to its chemical similarity to Fe, Ga can substitute for Fe in many biologic systems and inhibit Fe-dependent processes. We found that Ga inhibits Pseudomonas aeruginosa growth and biofilm formation and kills planktonic and biofilm bacteria in vitro. Ga works in part by decreasing bacterial Fe uptake and by interfering with Fe signaling by the transcriptional regulator pvdS. We also show that Ga is effective in 2 murine lung infection models. These data, along with the fact that Ga is FDA approved (for i.v. administration) and there is the dearth of new antibiotics in development, make Ga a potentially promising new therapeutic for P. aeruginosa infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Mechanisms of antibiotic resistance in bacterial biofilms
Stewart, P. S. (2002) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00196 · Cited by 1,385
Aminoglycoside antibiotics induce bacterial biofilm formation
Hoffman, L. R., D'Argenio, D. A., MacCoss, M. J., Zhang, Z., Jones, R. A., & Miller, S. I. (2005) · Nature · doi:10.1038/nature03912 · Cited by 1,321
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602138103 · Cited by 1,319
Schuster, M., Lostroh, C. P., Ogi, T., & Greenberg, E. P. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.7.2066-2079.2003 · Cited by 1,126
A component of innate immunity prevents bacterial biofilm development
Singh, P. K., Parsek, M. R., Greenberg, E. P., & Welsh, M. J. (2002) · Nature · doi:10.1038/417552a · Cited by 1,026
Self-citationWalters, M. C., Roe, F., Bugnicourt, A., Franklin, M. J., & Stewart, P. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.317-323.2003 · Cited by 988
Bacterial Iron Sources: From Siderophores to Hemophores
Wandersman, C., & Delepelaire, P. (2004) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123811 · Cited by 930
MEYER, J. M., & ABDALLAH, M. A. (1978) · Journal of General Microbiology · doi:10.1099/00221287-107-2-319 · Cited by 844
Iron and Pseudomonas aeruginosa biofilm formation
Banin, E., Vasil, M. L., & Greenberg, E. P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504266102 · Cited by 801
Siderophore-mediated signaling regulates virulence factor production in Pseudomonas aeruginosa
Lamont, I. L., Beare, P. A., Ochsner, U., Vasil, A. I., & Vasil, M. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092016999 · Cited by 584
Bjarnsholt, T., Jensen, P. Ø., Burmølle, M., Hentzer, M., Haagensen, J. A. J., Hougen, H. P., Calum, H., Madsen, K. G., Moser, C., Molin, S., et al. (2005) · Microbiology · doi:10.1099/mic.0.27463-0 · Cited by 500
Lack of development of new antimicrobial drugs: a potential serious threat to public health
Norrby, S. R., Nord, C. E., & Finch, R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)01283-1 · Cited by 491
Chelator-Induced Dispersal and Killing of Pseudomonas aeruginosa Cells in a Biofilm
Banin, E., Brady, K. M., & Greenberg, E. P. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.3.2064-2069.2006 · Cited by 473
Mechanisms of Therapeutic Activity for Gallium
Bernstein, L. R. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01383-8 · Cited by 446
Ochsner, U. A., Wilderman, P. J., Vasil, A. I., & Vasil, M. L. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03084.x · Cited by 403
Transcriptome of Uropathogenic Escherichia coli during Urinary Tract Infection
Snyder, J. A., Haugen, B. J., Buckles, E. L., Lockatell, C. V., Johnson, D. E., Donnenberg, M. S., Welch, R. A., & Mobley, H. L. T. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6373-6381.2004 · Cited by 381
Rachid, S., Ohlsen, K., Witte, W., Hacker, J., & Ziebuhr, W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3357-3363.2000 · Cited by 373
Synergistic and additive killing by antimicrobial factors found in human airway surface liquid
Singh, P. K., Tack, B. F., McCray, P. B., & Welsh, M. J. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.5.l799 · Cited by 341
Self-citationCornelis, P., & Matthijs, S. (2002) · Environmental Microbiology · doi:10.1046/j.1462-2920.2002.00369.x · Cited by 278
Iron and infection: the heart of the matter
Bullen, J. J., Rogers, H. J., Spalding, P. B., & Ward, C. G. (2005) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.11.010 · Cited by 273
Lactoferrin: a multifunctional glycoprotein.
Vorland, L. H. (1999) · APMIS · doi:10.1111/j.1699-0463.1999.tb01499.x · Cited by 252
Xu, Q., Dziejman, M., & Mekalanos, J. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337479100 · Cited by 226
Brown, M. R., Collier, P. J., & Gilbert, P. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.9.1623 · Cited by 206
A Distinct QscR Regulon in the Pseudomonas aeruginosa Quorum-Sensing Circuit
Lequette, Y., Lee, J.-H., Ledgham, F., Lazdunski, A., & Greenberg, E. P. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.9.3365-3370.2006 · Cited by 195
Biofilms, Antimicrobial Resistance, and Airway Infection
Prince, A. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmcibr021776 · Cited by 177
Rogan, M. P., Taggart, C. C., Greene, C. M., Murphy, P. G., O’Neill, S. J., & McElvaney, N. G. (2004) · The Journal of Infectious Diseases · doi:10.1086/423821 · Cited by 171
Chitambar, C., Matthaeus, W., Antholine, W. E., Graff, K. E., & O'Brien, W. (1988) · Blood · doi:10.1182/blood.v72.6.1930.1930 · Cited by 148
Brown, M. R., Anwar, H., & Lambert, P. A. (1984) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1984.tb00195.x · Cited by 148
Berlutti, F., Morea, C., Battistoni, A., Sarli, S., Cipriani, P., Superti, F., Ammendolia, M. G., & Valenti, P. (2005) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200501800407 · Cited by 122
Flamm, R. K., Weaver, M. K., Thornsberry, C., Jones, M. E., Karlowsky, J. A., & Sahm, D. F. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2431-2436.2004 · Cited by 122
Fatal Rhizopus Infections in Hemodialysis Patients Receiving Deferoxamine
Windus, D. W., STOKES, T. J., Julian, B. A., & FENVES, A. Z. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-5-678 · Cited by 110
Debrunner, P. G. (1983) · Science · doi:10.1126/science.220.4603.1266 · Cited by 110
Hassett, D. J., Woodruff, W. A., Wozniak, D. J., Vasil, M. L., Cohen, M. S., & Ohman, D. E. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.23.7658-7665.1993 · Cited by 106
Role of exotoxin A in inducing severe Pseudomonas aeruginosa infections in mice
Miyazaki, S., Matsumoto, T., Tateda, K., Ohno, A., & Yamaguchi, K. (1995) · Journal of Medical Microbiology · doi:10.1099/00222615-43-3-169 · Cited by 85
Pankhaniya, R. R., Tamura, M., Allmond, L. R., Moriyama, K., Ajayi, T., Wiener-Kronish, J. P., & Sawa, T. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000145588.79063.07 · Cited by 81
Kim, E.-J., Sabra, W. A., & Zeng, A. (2003) · Microbiology · doi:10.1099/mic.0.26276-0 · Cited by 74
The effect of passage and iron on the virulence of Pseudomonas aeruginosa
Forsberg, C. M., & Bullen, J. J. (1972) · Journal of Clinical Pathology · doi:10.1136/jcp.25.1.65 · Cited by 55
(1999)
Cited by
Antimicrobial activity of metals: mechanisms, molecular targets and applications
Lemire, J. A., Harrison, J. J., & Turner, R. J. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3028 · Cited by 2,746
Physiological heterogeneity in biofilms
Stewart, P. S., & Franklin, M. J. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1838 · Cited by 2,327
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Targeting microbial biofilms: current and prospective therapeutic strategies
Koo, H., Allan, R. N., Howlin, R. P., Stoodley, P., & Hall-Stoodley, L. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.99 · Cited by 1,800
Pseudomonas aeruginosa Biofilms
Thi, M. T. T., Wibowo, D., & Rehm, B. H. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228671 · Cited by 911
Metadata
- Authors
- Kaneko, Y., Thoendel, M., Olakanmi, O., Britigan, B. E., & Singh, P. K.
- Venue
- Journal of Clinical Investigation
- Published
- 2007-04-02
- Volume
- 117
- Issue
- 4
- Pages
- 877-888
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1978162577
- Cited by
- 661
- References
- 39
- FWCI
- 9.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.